The Evolving Landscape of Systemic Therapy for Liposarcoma. [PDF]
Kim HK, Sarkari A, Chow WA.
europepmc +1 more source
Tandem Duplications in UBTF Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic Dependency. [PDF]
Barajas JM +27 more
europepmc +1 more source
autoFISH: a modular toolbox for sequential single-molecule RNA FISH experiments. [PDF]
Weber C +11 more
europepmc +1 more source
Therapeutic Approaches Interfering with Nuclear Localization Signals: An Emerging Strategy for CNS-Related Diseases. [PDF]
Anyanwu M +3 more
europepmc +1 more source
Combination effect of Exportin 1 inhibitor (KPT-335) with doxorubicin or vincristine in canine lymphoma cell lines. [PDF]
Primarizky H +4 more
europepmc +1 more source
Dynamic Cellular Regulation of Proteasome Translocation and Phase Transition. [PDF]
Butcher C, Li J.
europepmc +1 more source
Protein biomarkers for response to XPO1 inhibition in haematologic malignancies
XPO1 (Exportin‐1) is the nuclear export protein responsible for the normal shuttling of several proteins and RNA species between the nucleocytoplasmic compartment of eukaryotic cells.
Skye Montoya +2 more
exaly +2 more sources
Pathogenic XPO1 variants cause a dominant neurodevelopmental disorder
Purpose: XPO1 functions in key cellular processes, including nucleo-cytoplasmic export and mitosis. The gene is deleted in a subset of patients with the 2p15p16.1 microdeletion syndrome, however no monogenic XPO1-related disorder has been described to ...
Richard H van Jaarsveld +2 more
exaly +5 more sources
XPO1 Expression Is a Poor-Prognosis Marker in Pancreatic Adenocarcinoma
International audiencePancreatic adenocarcinoma (PAC) is one of the most aggressive human cancers and new systemic therapies are urgently needed. Exportin-1 (XPO1), which is a member of the importin-β superfamily of karyopherins, is the major exporter of
Daniel Birnbaum +2 more
exaly +2 more sources

